PTRN vs REGN · rev $2.50B vs P/E 14, rev $14.34B
Pattern Group Inc. Series A Common Stock (PTRN) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Pattern Group Inc. Series A Common Stock (PTRN) is a software - application company listed on NASDAQ.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported PTRN revenue for 2025-12-31 was $2.50B. Net income was $16.2M. Revenue was up 39.3% from 2024-12-31 to 2025-12-31. PTRN currently screens at market cap $3.68B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
PTRN currently screens at market cap $3.68B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the PTRN and REGN stock pages for the full models.
Not investment advice.